Evidence map›Paper›PMID 36844217›Full record

ArticleFrontiers in medicine2023

Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis.

Simen Rykkje Grønningsæter, Johan Blakkisrud, Silje Selboe, Mona-Elisabeth Revheim, Øyvind Sverre Bruland, Tina Bjørnlund Bønsdorff, Stein Gunnar Larsen, Caroline Stokke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Normal Tissue Dosimetry of IntraperitonealJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Effect of IntraperitonealTechnology in cancer research & treatment
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simen Rykkje GrønningsæterDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Johan BlakkisrudDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Silje SelboeDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Mona-Elisabeth RevheimDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Øyvind Sverre BrulandDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Tina Bjørnlund BønsdorffOncoinvent AS, Oslo, Norway.
Stein Gunnar LarsenDepartment of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway.
Caroline StokkeDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Two ongoing phase I studies are investigating the use of radium-224 adsorbed to calcium carbonate micro particles ( Method: Six patients from the phase 1 trial in patients with colorectal cancer were included in this study. Two days after cytoreductive surgery, they were injected with 7 MBq of Results: The patients' median effective whole-body half-life of Conclusion: The number of patients treated with

Indexed as

alpha emitterperitoneal metastasisradiation safetyradium-224targeted alpha particle therapy

Identifiers

PMID36844217
PMCPMC9945525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.